[Low molecular weight heparin, fondaparinux and melagatran: new data and clinical studies].
Bauersachs
Rupert M
RM
Medizinische Klinik IV-Max-Ratschow Klinik, für Angiologie, Klinikum Darmstadt, Heidelberger Landstrasse 379 64297 Darmstadt. Rupert.Bauersachs@Klinikum-Darmstadt.de
D000789:Angina, Unstable / Q000188:drug therapy; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001384:Azetidines; D001596:Benzylamines; D000077425:Fondaparinux; D005998:Glycine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D011134:Polysaccharides / Q000627:therapeutic use*; D013927:Thrombosis / Q000517:prevention & control
D000925:Anticoagulants; D001384:Azetidines; D001596:Benzylamines; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; C109573:melagatran; D000077425:Fondaparinux; D005998:Glycine